Rein Therapeutics, Inc. (RNTX) › Weighted Average Diluted SharesRein Therapeutics, Inc. (RNTX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 4.44M2022-12-31: 4.54M2023-12-31: 4.60M2024-12-31: 17.94M2025-12-31: 25.44M25.44M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3125.44M+41.8%2026-03-26From 2025-01-012024-12-3117.94M+290.1%2026-03-26From 2024-01-012023-12-314.60M+1.3%2025-04-07From 2023-01-012022-12-314.54M+2.2%2024-04-15From 2022-01-012021-12-314.44M—2023-03-20From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)